GIVE MISS CALL ON :- +91 99774 99927



Lupin launches Tadalafil tablets USP
Lupin, in a press note to the exchanges on Tuesday, informed that it has launched Tadalafil tablets USP, 20mg, in the US markets after having received the approval of the United States Food and Drug Administration (USFDA) earlier. “Lupin’s Tadalafil tablets USP, 20mg, is the generic equivalent of Eli Lilly’s Adcirca Tablets, 20mg. It is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability,” the company said in a press note to the exchanges on Tuesday. As per IQVIA MAT data released in December 2018, Tadalafil tablets, 20mg, had annual sales of ~$474.3mn in the US. Lupin Ltd’s share price is currently at Rs812.80, down Rs6.4, or 0.78%, from its previous close of Rs819.20 on the BSE.

HEG soars 6% after Q3 net profits zoom 153%
Shares of HEG were trading in the green on Tuesday after the company posted solid net profit growth in its Q3FY19 results. The HEG stock soared ~6% on the BSE after the company’s net profit zoomed 153% in Q3FY19. HEG reported a sequential decline in earnings despite higher revenues due to increased raw material costs. Revenue in the quarter grew 121% yoy to Rs1,865cr (up 4% qoq). EBITDA stood at Rs1,313cr, up 136% yoy (down 4% qoq), with EBIDTA margins rising 427bps yoy to 70.4%. Net profit stood at Rs867cr, up 153% yoy (down 2.5% qoq). HEG Ltd, incorporated in 1972, is a leading manufacturer and exporter of graphite electrodes in India and operates the world’s largest single-site integrated graphite electrodes plant at Mandideep in Madhya Pradesh.

KNR Constructions declines ~2% post Q3 results
The company’s revenue grew 3.6% yoy to Rs448.89cr against Rs433.19cr in Q3FY18, beating the estimates of Rs432cr.Revenue grew by 3.6% yoy to Rs448.89cr against Rs433.19cr in Q3FY18, beating the estimate of Rs432cr. EBITDA for the quarter declined by 8.4% yoy to Rs90.12cr against Rs98.38cr in Q3FY18, beating the estimate of Rs77cr. The company has a strong EPC order book of ~Rs1,832cr. The company expects strong order inflow in the next few quarters due to governments Bharatmala projects. We expect the companys order book to grow by ~60% over FY18-20E on the back of rise in tendering of contracts.

Tata Motors global sales fall 12% in January
Tata Motors, in its filing to the exchanges on Tuesday, informed that global wholesales in January 2019, including Jaguar Land Rover, dropped 12% yoy in January 2019 to 1,00,572 units. Global wholesales of all Tata Motors’ commercial vehicles and Tata Daewoo range in January 2019 were at 40,886 units, lower by 9% over January 2018. Further, global wholesales of all passenger vehicles in January 2019 were at 59,686 units, lower by 15% compared to January 2018. Wholesales for Jaguar Land Rover were 41,676 vehicles (JLR number for January 2019 includes CJLR volumes of 2,712 units). Jaguar wholesales for the month were 12,904 vehicles, while Land Rover wholesales for the month were 28,772 vehicles.

CapitalStars Provides  Free Trial To Our Client…

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future cperformance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647.

Leave a Reply


Ouch! There was a server error.
Retry »

Sending message...


CapitalStars FORUM